Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01858285 · ClinicalTrials.gov registry record
Genetics of Epilepsy and Related Disorders
A clinical trial of Epilepsy and Epileptic Encephalopathy, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT01858285 is a study of Epilepsy and Epileptic Encephalopathy that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 5,000 participants, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01858285, a study of Epilepsy and Epileptic Encephalopathy, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to epilepsy and related disorders. These findings may help explain the broad spectrum of clinical characteristics and outcomes seen in people with epilepsy.
Conditions Studied
Interventions
- GENETIC Exome and/or whole genome sequencing
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2010-11 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01858285
The ClinicalTrials.gov registry entry for NCT01858285 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 921-participant average among 160 other Epilepsy trials with a reported enrollment target (443% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Exome and/or whole genome sequencing is the first listed.
NCT01858285 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01858285 about?
NCT01858285 is a clinical study titled "Genetics of Epilepsy and Related Disorders". Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to epilepsy and related disorders. These findings may help explain the broad spectrum of clinical characteristics and outcomes seen in people with epilepsy.
What is the current status of trial NCT01858285?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2010-11. Estimated completion is 2030-12.
What conditions does trial NCT01858285 study?
This clinical trial studies the following conditions: Epilepsy, Epileptic Encephalopathy.
What interventions are being tested in trial NCT01858285?
The interventions under investigation include: Exome and/or whole genome sequencing (GENETIC).
Who is sponsoring clinical trial NCT01858285?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01858285 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.